{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:24:50Z","timestamp":1782941090575,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009074","name":"Huaiyin Institute of Technology","doi-asserted-by":"publisher","award":["Z301B21529"],"award-info":[{"award-number":["Z301B21529"]}],"id":[{"id":"10.13039\/501100009074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008773","name":"Hainan Association for Science and Technology","doi-asserted-by":"publisher","award":["252102311217"],"award-info":[{"award-number":["252102311217"]}],"id":[{"id":"10.13039\/501100008773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22201091"],"award-info":[{"award-number":["22201091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109658","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T08:01:04Z","timestamp":1771315264000},"page":"109658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel platinum(IV) complexes trigger apoptosis and ferroptosis to conquer cisplatin resistance in triple-negative breast cancer"],"prefix":"10.1016","volume":"173","author":[{"given":"Guoxiu","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingguo","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109658_bb0005","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/acs.chemrev.8b00209","article-title":"Stimuli-responsive therapeutic metallodrugs","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.109658_bb0010","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1039\/c0dt00292e","article-title":"The status of platinum anticancer drugs in the clinic and in clinical trials","volume":"39","author":"Wheate","year":"2010","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2026.109658_bb0015","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1039\/D0SC00197J","article-title":"Interfering in apoptosis and DNA repair of cancer cells to conquer cisplatin resistance by platinum(IV) prodrugs","volume":"11","author":"Zhang","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.109658_bb0020","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1039\/C8SC00428E","article-title":"Triple action Pt(IV) derivatives of cisplatin","volume":"9","author":"Petruzzella","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.109658_bb0025","doi-asserted-by":"crossref","first-page":"12132","DOI":"10.1021\/acs.jmedchem.1c00770","article-title":"Structure\u2013activity relationships of triple-action platinum(IV) prodrugs with albumin-binding properties and immunomodulating ligands","volume":"64","author":"Fronik","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109658_bb0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ejmech.2019.02.041","article-title":"New NSAID-Pt(IV) prodrugs to suppress metastasis and invasion of tumor cells and enhance anti-tumor effect in vitro and in vivo","volume":"167","author":"Song","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109658_bb0035","doi-asserted-by":"crossref","first-page":"18556","DOI":"10.1002\/anie.202005362","article-title":"CAIXplatins","volume":"59","author":"Cao","year":"2020","journal-title":"Angew. Chem. Int. Edit."},{"key":"10.1016\/j.bioorg.2026.109658_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biomaterials.2017.12.001","article-title":"Self-assembly regulated anticancer activity of platinum coordinated selenomethionine","volume":"157","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioorg.2026.109658_bb0045","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1039\/C8CC03763A","article-title":"Reprogramming axial ligands facilitates the self-assembly of a platinum(iv) prodrug","volume":"54","author":"Fang","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2026.109658_bb0050","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.1021\/acs.jmedchem.1c02136","article-title":"Pt(IV) prodrugs with non-steroidal anti-inflammatory drugs in the axial position","volume":"65","author":"Spector","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109658_bb0055","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1021\/acs.jmedchem.1c00079","article-title":"Novel CK2-specific Pt(II) compound reverses cisplatin-induced resistance by inhibiting cancer cell stemness and suppressing DNA damage repair in non-small cell lung cancer treatments","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109658_bb0060","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1021\/acs.jmedchem.4c02509","article-title":"Platinum(IV) complexes trigger death receptors and natural killer cells to suppress breast cancer","volume":"68","author":"Cai","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109658_bb0065","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1039\/D3DT02358C","article-title":"A series of ligustrazine platinum(IV) complexes with potent anti-proliferative and anti-metastatic properties that exert chemotherapeutic and immunotherapeutic effects","volume":"52","author":"Chen","year":"2023","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2026.109658_bb0070","doi-asserted-by":"crossref","first-page":"14692","DOI":"10.1021\/acs.jmedchem.2c01224","article-title":"Pt(IV)-deferasirox prodrug combats DNA damage repair by regulating RNA N6-methyladenosine methylation","volume":"65","author":"Pan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109658_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202505930","article-title":"Evoking simultaneous ferroptosis and apoptosis by a dual-locked platinum (IV) prodrug for synergistic chemo-immunotherapy","volume":"64","author":"Meng","year":"2025","journal-title":"Angew. Chem. Int. Edit."},{"key":"10.1016\/j.bioorg.2026.109658_bb0080","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2026.109658_bb0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Angeli","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.109658_bb0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.109658_bb0095","doi-asserted-by":"crossref","first-page":"10036","DOI":"10.1021\/acs.jmedchem.3c00967","article-title":"Discovery of novel potent covalent glutathione peroxidase 4 inhibitors as highly selective ferroptosis inducers for the treatment of triple-negative breast cancer","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109658_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101977","article-title":"Ent-Kaurane diterpenoids induce apoptosis and ferroptosis through targeting redox resetting to overcome cisplatin resistance","volume":"43","author":"Sun","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioorg.2026.109658_bb0105","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3390\/cancers3011285","article-title":"Glutathione in cancer cell death","volume":"3","author":"Ortega","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.109658_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2026.109658_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904197","article-title":"Recent progress in ferroptosis inducers for cancer therapy","volume":"31","author":"Liang","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioorg.2026.109658_bb0120","article-title":"Emerging strategies of cancer therapy based on ferroptosis","volume":"30","author":"Shen","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioorg.2026.109658_bb0125","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1111\/cas.15869","article-title":"Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer","volume":"114","author":"Wang","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2026.109658_bb0130","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.freeradbiomed.2018.10.426","article-title":"Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer","volume":"129","author":"Shin","year":"2018","journal-title":"Free Radical Bio. Med."},{"key":"10.1016\/j.bioorg.2026.109658_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151887","article-title":"Glucose deprivation induces cisplatin resistance through upregulation of SLC7A11 (xCT) expression in endometrial cancer cells","volume":"766","author":"Aoyama","year":"2025","journal-title":"Biochem. Bioph. Res. Co."},{"key":"10.1016\/j.bioorg.2026.109658_bb0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4143\/crt.2016.572","article-title":"Ferroptosis","volume":"50","author":"Guo","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.bioorg.2026.109658_bb0145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11658-021-00271-y","article-title":"Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2\/Keap1\/xCT signaling","volume":"26","author":"Fu","year":"2021","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bioorg.2026.109658_bb0150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2016.07.035","article-title":"Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer","volume":"381","author":"Roh","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.109658_bb0155","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1021\/acs.bioconjchem.6b00353","article-title":"Combretastatin A-4 Analogue","volume":"27","author":"Huang","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bioorg.2026.109658_bb0160","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1021\/acs.inorgchem.8b03386","article-title":"Construction of dual stimuli-responsive platinum(IV) hybrids with NQO1 targeting ability and overcoming cisplatin resistance","volume":"58","author":"Fang","year":"2019","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109658_rf0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2015.07.031","article-title":"Xc\u2212 inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism","volume":"368","author":"Ma","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.109658_rf0170","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ctrv.2007.01.009","article-title":"Oxaliplatin for the treatment of cisplatin-resistant cancer","volume":"33","author":"Stordal","year":"2007","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bioorg.2026.109658_bb0170","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1021\/acs.jmedchem.9b00128","article-title":"Fuplatin","volume":"62","author":"Zhang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109658_bb0175","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1021\/acs.jmedchem.0c00343","article-title":"Anticancer melatplatin prodrugs","volume":"63","author":"Song","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109658_bb0180","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.109658_bb0185","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1021\/acs.chemrev.6b00204","article-title":"Photochemistry of transition metal hydrides","volume":"116","author":"Perutz","year":"2016","journal-title":"Chem. Rev."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682600194X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682600194X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:00:20Z","timestamp":1777464020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682600194X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S004520682600194X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109658","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel platinum(IV) complexes trigger apoptosis and ferroptosis to conquer cisplatin resistance in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109658"}}